title: BcL-xL conformational changes upon fragment binding revealed by NMR.
abstract: Protein-protein interactions represent difficult but increasingly important targets for the design of therapeutic compounds able to interfere with biological processes. Recently, fragment-based strategies have been proposed as attractive approaches for the elaboration of protein-protein surface inhibitors from fragment-like molecules. One major challenge in targeting protein-protein interactions is related to the structural adaptation of the protein surface upon molecular recognition. Methods capable of identifying subtle conformational changes of proteins upon fragment binding are therefore required at the early steps of the drug design process. In this report we present a fast NMR method able to probe subtle conformational changes upon fragment binding. The approach relies on the comparison of experimental fragment-induced Chemical Shift Perturbation (CSP) of amine protons to CSP simulated for a set of docked fragment poses, considering the ring-current effect from fragment binding. We illustrate the method by the retrospective analysis of the complex between the anti-apoptotic Bcl-xL protein and the fragment 4'-fluoro-[1,1'-biphenyl]-4-carboxylic acid that was previously shown to bind one of the Bcl-xL hot spots. The CSP-based approach shows that the protein undergoes a subtle conformational rearrangement upon interaction, for residues located in helices [Formula: see text]2, [Formula: see text]3 and the very beginning of [Formula: see text]5. Our observations are corroborated by residual dipolar coupling measurements performed on the free and fragment-bound forms of the Bcl-xL protein. These NMR-based results are in total agreement with previous molecular dynamic calculations that evidenced a high flexibility of Bcl-xL around the binding site. Here we show that CSP of protein amine protons are useful and reliable structural probes. Therefore, we propose to use CSP simulation to assess protein conformational changes upon ligand binding in the fragment-based drug design approach.
authors.affiliation: UMR5280/Université de Lyon/Université Lyon 1, Institut des Sciences Analytiques, Villeurbanne, France.
authors.forename: Clémentine
authors.initials: C
authors.lastname: Aguirre
authors.forename: Tim
authors.initials: T
authors.lastname: Ten Brink
authors.forename: Olivier
authors.initials: O
authors.lastname: Walker
authors.forename: Florence
authors.initials: F
authors.lastname: Guillière
authors.forename: Dany
authors.initials: D
authors.lastname: Davesne
authors.forename: Isabelle
authors.initials: I
authors.lastname: Krimm
mesh_terms: D001565:Benzoates / Q000737:chemistry*; D001665:Binding Sites; D001713:Biphenyl Compounds / Q000737:chemistry*; D055808:Drug Discovery / Q000379:methods; D006801:Humans; D062105:Molecular Docking Simulation; D019906:Nuclear Magnetic Resonance, Biomolecular; D011485:Protein Binding; D020836:Protein Structure, Quaternary; D017433:Protein Structure, Secondary; D040681:Structural Homology, Protein; D013499:Surface Properties; D013816:Thermodynamics; D051020:bcl-X Protein / Q000737:chemistry*
chemical_list: C494811:BCL2L1 protein, human; D001565:Benzoates; D001713:Biphenyl Compounds; D051020:bcl-X Protein